Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Consolidated Net Income: 2019-2024

Historic Consolidated Net Income for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $117.5 million.

  • Harmony Biosciences Holdings' Consolidated Net Income rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 44.38%. This contributed to the annual value of $117.5 million for FY2024, which is 1.78% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Consolidated Net Income of $117.5 million as of FY2024, which was up 1.78% from $115.4 million recorded in FY2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Consolidated Net Income peaked at $181.5 million during FY2022, and registered a low of -$30.5 million during FY2020.
  • For the 3-year period, Harmony Biosciences Holdings' Consolidated Net Income averaged around $138.1 million, with its median value being $117.5 million (2024).
  • In the last 5 years, Harmony Biosciences Holdings' Consolidated Net Income skyrocketed by 486.50% in 2022 and then tumbled by 36.39% in 2023.
  • Yearly analysis of 5 years shows Harmony Biosciences Holdings' Consolidated Net Income stood at -$30.5 million in 2020, then spiked by 201.35% to $30.9 million in 2021, then surged by 486.50% to $181.5 million in 2022, then slumped by 36.39% to $115.4 million in 2023, then climbed by 1.78% to $117.5 million in 2024.